Transforming Physician Identification: Leverage Real-Time Data to Reach Every Eligible Patient
Date: June 2025
Time: N/A
Location: Online
Pharma and biotech companies today face significant hurdles with identifying physicians that are treating patients relevant to their therapies. It is also challenging to cut through the noise and capture the attention of physicians at just the right time, before they make treatment decisions.
Join us for this one hour deep dive with a panel of experts and industry leaders to gain valuable insights and guidance on diagnostic and precision medicine testing. Learn how to revolutionize your approach to physician engagement for enabling more informed treatment decisions, fewer missed patients, and the chance for every eligible patient to receive optimal therapy.
We explored:
-
Strategies and tactics that optimize your launch and brand strategy to improve future commercial projections
-
Why physician identification and engagement within 24 hours following a positive test result is key to enabling a therapy to succeed
-
Steps for achieving above industry standard physician and key stakeholder engagement rates
- Ways to close the gap between testing and clinical response, driving peer-to-peer, just-in-time discussions that drive greater therapy adoption
-
How to leverage timely, omnichannel engagement to enhance field force planning and increase prescriptions
Speakers:
Jordan Clark
Chief Data Officer
As Chief Data Officer at Diaceutics, Jordan spearheads comprehensive data strategy, spanning acquisition engineering and data science, to deliver cutting-edge analytics to our clients and laboratories. With over a decade of experience at Diaceutics, he has cultivated a profound understanding of the critical role real-world data plays in optimizing precision medicine. Jordan's
academic and professional credentials in biomedical and clinical sciences, coupled with his state licensure as a hematology scientist, underscore his expertise. Additionally, his renowned proficiency in bioinformatics and biomarker testing, honed through his involvement with UK NEQAS, further solidifies his leadership in the field.
Kenneth Ruppel
VP Scientific & Medical Services
Gunjan Aggarwal
Executive Director, (Insights and Decision Science), Novartis
Gunjan Aggarwal is a healthcare data strategist with extensive experience in digital transformation, analytics, and precision medicine. As Executive Director at Novartis, she leads initiatives that enhance data-driven marketing and patient-centric solutions. Passionate about reimagining healthcare, Gunjan applies AI and emerging technologies to drive operational efficiency and innovation.
ConnectMichelle Shiller, PhD.
Medical Director Cancer Genetics and Precision Medicine Texas Cancer Interception Institute
Dr. Michelle Shiller is a recognized leader in integrating molecular diagnostics and precision medicine into clinical practice. She is board certified in Anatomic, Clinical, and Molecular Genetic Pathology, with advanced training from the Mayo Clinic. A passionate advocate for clinical education, Dr. Shiller is committed to empowering physicians with the knowledge and confidence to make timely, informed treatment decisions—especially in complex and evolving areas like oncology and rare disease.
ConnectSubmit your details to view the recording
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network ®
Newsletter sign up
READY TO DO COMMERCIALIZATION DIFFERENTLY?
You might also be interested in?
Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks
Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.